Cargando…
Long-term effects of increased adoption of artemisinin combination therapies in Burkina Faso
Artemisinin combination therapies (ACTs) are the WHO-recommended first-line therapies for uncomplicated Plasmodium falciparum malaria. The emergence and spread of artemisinin-resistant genotypes is a major global public health concern due to the increased rate of treatment failures that result. This...
Autores principales: | Zupko, Robert J., Nguyen, Tran Dang, Somé, Anyirékun Fabrice, Tran, Thu Nguyen-Anh, Gerardin, Jaline, Dudas, Patrick, Giang, Dang Duy Hoang, Tran, Kien Trung, Wesolowski, Amy, Ouédraogo, Jean-Bosco, Boni, Maciej F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10021447/ https://www.ncbi.nlm.nih.gov/pubmed/36962300 http://dx.doi.org/10.1371/journal.pgph.0000111 |
Ejemplares similares
-
National-scale simulation of human movement in a spatially coupled individual-based model of malaria in Burkina Faso
por: Zupko, Robert J., et al.
Publicado: (2023) -
Role of Seasonal Importation and Random Genetic Drift on Selection for Drug-Resistant Genotypes of Plasmodium falciparum in High Transmission Settings
por: Zupko, Robert J., et al.
Publicado: (2023) -
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda
por: Zupko, Robert J., et al.
Publicado: (2023) -
Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change
por: Zongo, Issaka, et al.
Publicado: (2020) -
Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2016)